Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses

ClinicalTrials.gov ID: NCT01244516

Public ClinicalTrials.gov record NCT01244516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the clinical performance of three silicone hydrogel contact lenses over a 2 week period.

Study identification

NCT ID: NCT01244516
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Enrollment: 540 participants

Conditions and interventions

Conditions

Myopia

Interventions

Device

Eligibility (public fields only)

Age range: 18 Years to 39 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2010
Primary completion: Oct 31, 2010
Completion: Oct 31, 2010
Last update posted: Jun 18, 2018

2010

United States locations

U.S. sites: 35
U.S. states: 22
U.S. cities: 34

Facility	City	State	ZIP	Site status
Not listed	Brea	California	92891	—
Not listed	Campbell	California	95008	—
Not listed	Cupertino	California	95014	—
Not listed	Mission Viejo	California	92691	—
Not listed	Colorado Springs	Colorado	80909	—
Not listed	Bridgeport	Connecticut	06610	—
Not listed	Aventura	Florida	33180	—
Not listed	Jacksonville	Florida	32256	—
Not listed	Tallahassee	Florida	32308	—
Not listed	Tampa	Florida	33625	—
Not listed	Winter Park	Florida	32792	—
Not listed	Roswell	Georgia	30076	—
Not listed	Bloomington	Illinois	61701	—
Not listed	Mishawaka	Indiana	46545	—
Not listed	Pittsburg	Kansas	66763	—
Not listed	Boston	Massachusetts	02114	—
Not listed	Independence	Missouri	64055	—
Not listed	Raytown	Missouri	64133	—
Not listed	Closter	New Jersey	07624	—
Not listed	New York	New York	10001	—
Not listed	Raleigh	North Carolina	27615	—
Not listed	North Olmsted	Ohio	44070	—
Not listed	Powell	Ohio	43065	—
Not listed	Kittanning	Pennsylvania	16201	—
Not listed	Warwick	Rhode Island	02888	—
Not listed	Chamberlain	South Dakota	57325	—
Not listed	Bartlett	Tennessee	38134	—
Not listed	Brentwood	Tennessee	37027	—
Not listed	Memphis	Tennessee	38119	—
Not listed	Tyler	Texas	75701	—
Not listed	Tyler	Texas	75703	—
Not listed	Salt Lake City	Utah	84106	—
Not listed	Burlington	Vermont	05401	—
Not listed	Salem	Virginia	24153	—
Not listed	Virginia Beach	Virginia	23455	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01244516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 18, 2018 · Synced Sep 2, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01244516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →